Skip to main content
. 2022 Sep 3;14(17):4323. doi: 10.3390/cancers14174323

Figure 3.

Figure 3

Kaplan–Meier estimates of the progression-free survival (PFS) of the entire study population (n = 80). Median PFS was 1.9 (95% CI, 1.822–1.978) months. PFS, progression-free survival; mo, month; CI, confidence interval.